Endo Reiterates US Generics Environment Is ‘Challenging’

Follows Recent Comments By Sandoz And Teva

chart
Endo sees a "fair amount of competition impact" in 2021 • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Generics

More from Products